Growing Clinical Experience With over 85,000 eye exams conducted across 45 clinical trials, 20/20 Onsite demonstrates substantial experience and a proven track record in supporting complex ophthalmic assessments, indicating strong potential for expanding partnerships with pharmaceutical and biotech firms conducting large-scale clinical research.

Innovative Trial Support The company's ability to reduce participant dropout rates to just 9% positions it as a valuable partner for clinical trial sponsors seeking to improve retention, accelerate timelines, and ensure high-quality ocular endpoint data, creating opportunities for targeted sales in the clinical research industry.

Strategic Partnerships Collaborations with organizations like The Vision Council Foundation, Southbridge Public Schools, and the New England College of Optometry highlight opportunities to expand into public health initiatives, educational programs, and non-traditional markets where mobile eye care can add value.

Recognition and Growth Receiving awards like the Safety Excellence Award underscores 20/20 Onsite’s commitment to quality and safety, making it an attractive partner for organizations prioritizing regulatory compliance, risk management, and high standards in clinical and community outreach services.

Market Position and Revenue With a revenue range of $25M to $50M and recent funding, the company is well-positioned for growth, presenting opportunities for sales efforts focused on expanding its service offerings, geographic reach, and technology integrations within the rapidly evolving mobile ophthalmic care market.